# Eribulin

## Halaven inj 1mg/2mL

| 藥物代碼 | IHALA |
| :--- | :--- |
| 適應症 | Treatment of Breast cancer, metastatic. |
| 副作用 | &gt;10%:Central nervous system: Fatigue \(54%\), fever \(21%\), headache \(19%\)Dermatologic: Alopecia \(45%\)Gastrointestinal: Nausea \(35%\), constipation \(25%\), weight loss \(21%\), anorexia \(20%\), diarrhea \(18%\), stomatitis \(5% to 18%\), vomiting \(18%\)Hematologic: Neutropenia \(82%; grades 3: 28%; grade 4: 29%; nadir: 13 days; recovery: 8 days\), anemia \(58%; grades 3/4: 2%\)Hepatic: ALT increased \(18%\)Neuromuscular & skeletal: Weakness \(54%\), peripheral neuropathy \(35%; grades 3/4: ?8%\), arthralgia/myalgia \(22%\), back pain \(16%\), bone pain \(12%\), limb pain \(11%\)Respiratory: Dyspnea \(16%\), cough \(14%\)1% to 10%:Cardiovascular: Peripheral edemaCentral nervous system: Depression, dizziness, insomniaDermatologic: RashEndocrine & metabolic: HypokalemiaGastrointestinal: Mucosal inflammation \(9%\), abdominal pain, dyspepsia, taste alteration, xerostomiaGenitourinary: Urinary tract infection \(10%\)Hematologic: Neutropenic fever \(5%\), thrombocytopenia \(grades 3/4: 1%\)Neuromuscular & skeletal: Muscle spasmOcular: Lacrimation increasedRespiratory: Upper respiratory infection&lt;1% \(Limited to important or life-threatening\): Pancreatitis, pharyngolaryngeal pain, sepsis |
| 禁忌 | Hypersensitivity to eribulin mesylate, halichondrin B, or its chemical derivatives. |
| 藥物保存方式 | 室溫 |
| 用法用量 | 1.4 mg/m2 on days 1 and 8 of a 21-day treatment cycle until disease progression or unacceptable toxicity. |
| 肝功能異常 | 需 調 整 劑 量  Mild hepatic impairment \(Child-Pugh class A\): Reduce initial dose to 1.1 mg/m2. Moderate hepatic impairment \(Child-Pugh class B\): Reduce initial dose to 0.7 mg/m2. |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 尚未確立 |
| 孕期用藥建議 | Contraindicated |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | Contraindicated 哺乳期使用禁忌 |
| 附帶說明 | 廠商 懷孕分級建立: D |
| 注射劑給藥建議途徑 | IVD |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | 【N/S】 仿單建議 |
| IVP 用法建議 | N/A |
| IVD 用法建議 | 可給予未稀釋或以100 mL 0.9% 氯化鈉溶液稀釋後的注射液。 靜脈注射給藥時間為2至5分鐘。 |
| 注意事項 | 不可以葡萄糖溶液稀釋或含葡萄糖溶液之靜脈注射管線給藥。 |

